X4 PHARMACEUTICALS, INC Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
X4 PHARMACEUTICALS, INC (XFOR) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $810.00 thousand as of 2018-12-31, per its 10-K filed 2020-03-12.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2020-03-12
- 2018-12-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $810.00K.
- 2018-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $387.00K.
- 2018-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $662.00K.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2018-12-31 | $810.00K 10-K · filed 2020-03-12 |
| 2018-09-30 | $387.00K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $662.00K 10-Q · filed 2018-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |